Annexon • ANNX
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Douglas Love, Esq.$412.8M
Market Cap • 17/04/20242011
(há 13 anos)
2020
(4 years ago)
NASDAQ
Listagem
Brisbane
Sede • California80
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ANNXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.